共 189 条
[1]
Geyer M(2011)The pathogenesis of systemic sclerosis revisited Clin Rev Allergy Immunol 40 92-103
[2]
Muller-Ladner U(2008)The immunobiology of systemic sclerosis Semin Arthritis Rheum 38 132-60
[3]
Gu YS(2014)Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin Ann Rheum Dis 73 1864-1872
[4]
Kong J(2010)Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus Nat Genet 42 426-429
[5]
Cheema GS(2013)Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors Ann Rheum Dis 72 1382-1389
[6]
Keen CL(2010)Poly(I:C) drives type I IFN- and TGFbeta-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis J Invest Dermatol 130 2583-2593
[7]
Wick G(2015)The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis Ann Rheum Dis 75 1567-1573
[8]
Gershwin ME(2011)Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis Clin Rheumatol 30 231-237
[9]
Mathes AL(2011)An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis Ann Rheum Dis 70 1115-1121
[10]
Christmann RB(2011)Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis Arthritis Res Ther 13 R18-1027